Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1995-09-13
1999-08-10
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4241931, 4242771, 514 2, 530300, 530350, A61K 3800, A61K 3900, A61K 3512
Patent
active
059355760
ABSTRACT:
The present invention relates to immunogenic complexes of heat shock proteins (hsp) noncovalently bound to exogenous antigenic molecules which when administered to an individual elicit specific immunological responses in the host. Methods of prevention and treatment of cancer and infectious disease are provided.
REFERENCES:
patent: 4690915 (1987-09-01), Rosenberg
patent: 5188964 (1993-02-01), McGuire et al.
patent: 5232833 (1993-08-01), Sanders et al.
patent: 5348945 (1994-09-01), Berberian et al.
Martin et al., (1986) "Role of Murine Tumor Models in Cancer Treatment Research", Cancer Research 46:2189-2192.
Nieland et al., (1996) "Isolation of an immunodominant viral peptide that is endogenously bound to the strees protein GP96/GPR94", Proc. Natl. Acad. Sci. USA 93:6135-6139.
Suto et al., (1995) "A Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides", Science 269:1585-1588.
Udono et al., (1994) "Comparison of Tumor-Specific Immunogenicities of Stress-Induced Proteins gp96, hsp90, hsp70", J. Immunol. 152:5398-5403.
Mule et al., (1984) "Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2", Science 225:1487-1489.
Aldovini et al. (1992) "The New Vaccines", Technology Review pp. 24-31.
Barrios et al. (1992) "Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines that can circumvent the need for adjuvants and Bacillus Calmette Guerin priming", Eur. J. Immunol. 22:1365-1372.
Basombrio (1970) "Search for common antigenicities among twenty-five sacrcomas induced by methylcholanthrene", The Institute for Cancer Research 30:2458-2462.
Blachere et al. (1993) "Heat Shock Protein Vaccines Against Cancer," Journal of Immunotherapy 14:352-356.
Blachere and Srivastava (1993) "Immunization with GP96 heat shock proteins isolated from tumors or influenza virus infected cells elicits MHC-restricted, antigen-specific cytotoxic T lymphocytes against the corresponding cells", J. Cellular Biochem. Keystone Symposia NZ502, p. 124.
Boon "Toward a genetic analysis of tumor rejection antigens", Advances in Cancer Research 58:177-210, 1992.
Cohen (1993) "Cancer Vaccines Get A Shot In The Arm", Science 262:841-843.
Craig (1993) "Chaperones: Helpers Along the Pathways to Protein Folding", Science 260:1902-1904.
Elliott et al. (1990) "Naturally Processed Peptides", Nature 348:195-197.
Falk et al. (1991) "Allele-specific Motifs Revealed by Sequencing of Self-peptides Eluted from MHC Molecules", Nature 351:290-296.
Falk et al. (1990) "Cellular Peptide Composition Governed by Major Histocompatibility Complex Class I Molecules", Nature 348:248-251.
Fedweg and Srivastava "Evidence for biochemical heterogeneity of gp96 heat shock protein/tumor rejecion antigen", Mount Sinai School of Medicine NZ 206, p. 108.
Flynn et al. (1989) "Peptide binding and release by proteins implicated as catalysts of protein assembly", Science 245:385-390.
Flynn et al. (1991) "Peptide-binding Specificity of the Molecular Chaperone BiP", Nature 353:726-730.
Franklin (1993) "Making vaccines fit the cancer", New Scientist 140:17.
Gething et al. (1992) "Protein Folding in the Cell", Nature 355:33-45.
Globerson and Feldman (1964) "Antigenic specificity of 32(6):1229-1242.
Jakob et al. (1993) "Small Heat Shock Proteins Are Molecular Chaperones", J. Biol. Chem. 268:1517-1520.
Jardetzky et al. (1991) "Identification of Self Peptides Bound to Purified HLA-B27", Nature 353:326-329.
Lakey et al. (1987) "Identification of a peptide binding protein that plays a role in antigen presentation", Proc. Natl. Acad. Sci. USA 84:1659-1663.
Lanzavecchia (1993) "Identifying Strategies for Immune Intervention", Science 260:937-944.
Levy (1991) "ATP is Required for In Vitro Assembly of MHC Class I Antigens but Not for Transfer of Peptides across the ER Membrane", Cell 67:265-274.
Li and Srivastava (1993) "Tumor rejection antigen gp96/grp94 is an ATPase: Implications for protein folding and antigen presentation", EMBO J. 12(8):3143-3151.
Lindquist and Craig (1988) "The heat-shock proteins", Ann. Rev. Genet. 22:631-677.
Luescher et al. (1991) "Specific Binding of Antigenic Peptides to Cell-associated MHC Clas I Molecules", Nature 351:72-77.
Lukacs et al. (1993) "Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors", J. Exp. Med. 178:343-348.
Lussow et al. (1991) "Mycobacterial heat-shock proteins as carrier molecules", Eur. J. Immunol. 21:2297-2302.
Madden et al. (1991) "The Structure of HLA-B27 Reveals Nonamer Self-peptides Bound in an Extended Conformation", Nature 353:321-325.
Maki et al. (1993) "Mapping of the Genes for Human Endoplasmic Reticular Heat Shock Protein gp96/grp94", Somatic Cell Mol. Genetics 19(1):73-81.
Maki et al. (1990) "Human homologue of murine tumor rejection antigen gp96: 5'-Regulatory and coding regions and relationship to stress-induced proteins", Proc. Natl. Acad. Sci. USA 87:5658-5663.
McCall et al. (1989) "Biotherapy: A New Dimension in Cancer Treatment", Biotechnology 7:231-240.
Melnick (1985) "Virus Vaccines: An Overview", Proceedings of the First Annual Southwest Foundation for Biomedical Research International Symposium, Houston, Texas, Nov. 8-10, 1984, American Society for Microbiology pp. 1-13.
Nelson et al. (1992) "The Translation Machinery and 70 kd Heat Shock Protein Cooperate in Protein Synthesis", Cell 71:97-105.
Palladino et al. (1987) "Expression of shared tumor-specific antigen by two chemically induced BALB/c sarcomas", Cancer Research 47:5074-5079.
Prehn and Main (1957) "Immunity to methylcholanthrene-induced sarcomas", Journal of the National Cancer Institute 18(6):769-778.
Rothman (1989) "Polypeptide Chain Binding Proteins: Catalysts of Protein Folding and Related Processes in Cells", Cell 59:591-601.
Rotzschke et al. (1990) "Isolation and Analysis of Naturally Processed Viral Peptides as Recognized by Cytotoxic T cells", Nature 348:248-251.
Salk et al. (1993) "A Strategy for Prophylactic Vaccination Against HIV", Science 260:1270-1272.
Schumacher et al. (1991) "Peptide Selection by MHC Class I Molecules", Nature 350:703-706.
Srivastava et al. (1991) "Protein Tumor Antigens", Curr. Opin. Immunol. 3:654-658.
Srivastava et al. (1984) "The Serologically Unique Cell Surface Antigen of Zajdela Ascitic Hepatoma is also its Tumor-Associated Transplantation Antigen", Int. J. Cancer 33:417-422.
Srivastava et al. (1989) "Identification of a Human Homologue of the Murine Tumor Rejection Antigen GP96," Cancer Res. 49:1341-1343.
Srivastava et al. (1988) "Individually Distinct Transplantation Antigens of Chemically Induced Mouse", Immunology Today 9:78-83.
Srivastava et al. (1988) "Chromosonal Assignment of the Gene Encoding the Mouse Tumor Rejection Antigen gp96", Immunogenetics 28:205-207.
Srivastava et al. (1987) "5'-Structural analysis of genes encoding polymorphic antigens of chemically induced tumors", Proc. Natl. Acad. Sci. USA 84:3807-3811.
Srivastava et al. (1993) "Peptide-Binding Heat Shock Proteins in the Endoplasmic Reticulum: Role in Immune Response to Cancer and in Antigen Presentation", Advances in Cancer Research 62:153-177.
Srivastava and Maki (1991) "Stress-induced proteins in immune response cancer", Microbiol. Immunol. 167:109-123.
Srivastava and Heike (1991) "Tumor-specific immunogenicity of stress-induced proteins: Convergence of two evolutionary pathways of antigen presentation?", Seminars in Immunology 3:57-64.
Srivastava et al. (1986) "Tumor rejection antigens of chemically induced sarcomas of inbred mice", Proc. Natl. Acad. Sci. USA 83:3407-3411.
Subbarao et al. (1992) "A General Overview of Viral Vaccine Development," Genetically Engineered Vaccines 327:51-57.
Szikora et al. (1990) "Structure of the gene of tum-transplantation antigen P35B presence of a point mutation in the antigenic allele", EMBO J. 9(4):1041-1050.
Udono (1993) "Heat shock proteins HSP70, HSP90 and GP96 elicit tumor specific immunity to the tumors from which they are isolated", J. Cell. Biochem. Sup
Fordham University
Johnson Nancy A.
Scheiner Toni R.
LandOfFree
Compositions and methods for the treatment and prevention of neo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment and prevention of neo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment and prevention of neo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117576